ApoE4 has been shown to reduce the clearance and increase the deposition of Aβ in plaques and to decrease metabolic activity compared to ApoE3 [264], while ApoE2 has been associated with a reduced risk of AD [265]. The gene discussed is APOE; the disease is Alzheimer disease.